<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>update on R/Pharma</title>
    <link>https://rinpharma.com/categories/update/</link>
    <description>Recent content in update on R/Pharma</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 31 Aug 2020 20:57:25 +0000</lastBuildDate>
    
	<atom:link href="https://rinpharma.com/categories/update/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Introducing Our 2020 Keynote Speakers</title>
      <link>https://rinpharma.com/blog/post.3/</link>
      <pubDate>Mon, 31 Aug 2020 20:57:25 +0000</pubDate>
      
      <guid>https://rinpharma.com/blog/post.3/</guid>
      <description>The annual R/Pharma gathering attracts professionals from industry, academia and regulatory alike to come together to share and discuss the use of R in pharma, including progress, findings and achievements across various areas of interest such as machine learning, reproducible research, regulatory compliance and validation, safety monitoring, clinical trials, drug discovery, research &amp;amp; development, PK/PD/pharmacometrics, genomics, diagnostics, immunogenicity and more.</description>
    </item>
    
    <item>
      <title>Call For Talks</title>
      <link>https://rinpharma.com/blog/post.2/</link>
      <pubDate>Fri, 14 Aug 2020 20:57:25 +0000</pubDate>
      
      <guid>https://rinpharma.com/blog/post.2/</guid>
      <description>Call for talks has now closed. Registration details will be available shortly.</description>
    </item>
    
    <item>
      <title>The what and the why for R/Pharma</title>
      <link>https://rinpharma.com/blog/post.1/</link>
      <pubDate>Wed, 03 Jun 2020 20:57:25 +0000</pubDate>
      
      <guid>https://rinpharma.com/blog/post.1/</guid>
      <description>By design, R / Pharma is deliberately a smaller conference in terms of attendance in order to encourage maximum opportunities for direct interaction with speakers.</description>
    </item>
    
  </channel>
</rss>